Stockreport

Spectrum Pharmaceuticals Provides Strategy Update for Poziotinib Development Program

Spectrum Pharmaceuticals, Inc.  (SPPI) 
Last spectrum pharmaceuticals, inc. earnings: 2/27 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.sppirx.com/investor-relations
PDF ZENITH20 Phase 2 clinical trial amended to include new dosing regimens aimed at improving therapeutic indexManagement to host webcast and conference call today to review [Read more]